Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SRRK — Scholar Rock Holding Corp

CIK 1423053 MIAMI, FL
Back to SRRK Full portfolio

Position in SRRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,251,805
-$26,031,473 QoQ
Shares Held
331,851
-63.2% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 304 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRRK Over Time

Shares Held

Position Value (USD)

Derivatives in SRRK

reported options exposure · as of Jun 30, 2026
CallValue
$1,463,000
CallShares
26,600
PutValue
$5,566,000
PutShares
101,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. SRRK ranks #68 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in SRRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,566,000 101,200
2026-06-30 $18,251,805 331,851
2026-06-30 $1,463,000 26,600
2026-03-31 $3,038,088 61,800
2026-03-31 $44,283,278 900,799
2026-03-31 $1,174,924 23,900
2025-12-31 $1,880,935 42,700
2025-12-31 $1,554,965 35,300
2025-12-31 $21,846,420 495,946
2025-09-30 $5,485,452 147,300
2025-09-30 $5,496,624 147,600
2025-09-30 $5,012,875 134,610
2025-06-30 $1,746,206 49,300
2025-06-30 $1,416,800 40,000
2025-06-30 $34,592,057 976,625
2025-03-31 $31,106,700 967,549
2025-03-31 $900,200 28,000
2025-03-31 $1,195,980 37,200
2024-12-31 $4,291,746 99,300
2024-12-31 $2,774,724 64,200
2024-12-31 $74,254,509 1,718,059
2024-09-30 $6,275,626 783,474
2024-09-30 $243,504 30,400
2024-09-30 $252,315 31,500
2024-06-30 $941,255 112,996
2024-06-30 $114,954 13,800
2024-06-30 $63,308 7,600
2024-03-31 $97,680 5,500
2024-03-31 $179,376 10,100
2024-03-31 $11,451,452 644,789
2023-12-31 $406,080 21,600
2023-12-31 $10,130,379 538,850
2023-12-31 $56,400 3,000
2023-09-30 $50,410 7,100
2023-09-30 $20,590 2,900
2023-09-30 $324,612 45,720
2023-03-31 $42,400 5,300
2023-03-31 $20,000 2,500
2023-03-31 $865,072 108,134
2022-12-31 $12,670 1,400
2022-12-31 $1,051,274 116,163
2022-12-31 $2,715 300
2022-09-30 $2,100,662 303,126
2022-06-30 $1,207,069 219,867
2022-06-30 $353,007 64,300
2022-03-31 $2,883,659 223,713
2022-03-31 $1,078,893 83,700
2021-09-30 $2,693,440 81,570
2021-06-30 $4,351,790 150,581
2021-03-31 $212,772 4,200

Report a Problem

Category
Description
Email (optional, for follow-up)